Letrozole and norethisterone acetate in rectovaginal endometriosis
- PMID: 17331508
- DOI: 10.1016/j.fertnstert.2006.12.027
Letrozole and norethisterone acetate in rectovaginal endometriosis
Abstract
This open-label prospective study evaluated the efficacy of letrozole (2.5 mg/day) combined with norethisterone acetate (2.5 mg/day) in the treatment of pain symptoms related to the presence of rectovaginal endometriosis. The treatment significantly and quickly decreased the intensity of symptoms, but pain recurred at 3-month follow-up; five women underwent surgery during the follow-up, and histologic examination of rectovaginal nodules revealed the presence of active endometriotic lesions.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
